Suscribirse

Apparent diffusion coefficient analysis of solid tissue helps distinguish borderline from invasive malignant adnexal masses rated O-RADS MRI 4 - 28/09/24

Doi : 10.1016/j.diii.2024.05.004 
Rimeh Bourourou a, , Stephanie Nougaret b, Andrea Rockall c, Marc Bazot a, d, Leo Razakamanantsoa a, d, Isabelle Thomassin-Naggara a, d

EURAD Study Group

a Assistance Publique-Hôpitaux de Paris, Department of Imaging and Interventional Radiology, Hôpital Tenon, 75020, Paris, France 
b Department of Radiology, Montpellier Cancer Institute and Montpellier Research Cancer Institute, PINKcc Lab, U1194, 34090, Montpellier, France 
c Division of Surgery and Cancer, Imperial College London, Hammersmith Campus, SW7 2AZ, London, UK 
d Sorbonne Université, INSERM UMR S 938, CRSA, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, 75012, Paris, France 

Corresponding author.

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

ADC value of solid tissue in borderline ovarian masses is greater (1.310 × 10−3 mm2/s) than that in benign masses (1.035 × 10−3 mm2/s).
ADC value of solid tissue in benign ovarian masses is significantly greater than that in invasive masses (0.850 × 10−3 mm2/s).
All adnexal masses rated O-RADS MRI 4 with a mural nodule exhibiting an ADC value < 1.08 10−3 mm2/s are invasive and may potentially be upstaged to O-RADS MRI 5 category.

El texto completo de este artículo está disponible en PDF.

Abstract

Purpose

The purpose of this study was to evaluate the contribution of apparent diffusion coefficient (ADC) analysis of the solid tissue of adnexal masses to optimize tumor characterization and possibly refine the risk stratification of the O-RADS MRI 4 category.

Materials and methods

The EURAD cohort was retrospectively analyzed to select all patients with an adnexal mass with solid tissue and feasible ADC measurements. Two radiologists independently measured the ADC values of solid tissue, excluding necrotic areas, surrounding structures, and magnetic susceptibility artifacts. Significant differences in diffusion quantitative parameters in the overall population and according to the morphological aspect of solid tissue were analyzed to identify its impact on ADC reliability. Receiver operating characteristics curve (ROC) was used to determine the optimum cutoff of the ADC for distinguishing invasive from non-invasive tumors in the O-RADS MRI score 4 population.

Results

The final study population included 180 women with a mean age of 57 ± 15.5 (standard deviation) years; age range: 19–95 years) with 93 benign, 23 borderline, and 137 malignant masses. The median ADC values of solid tissue was greater in borderline masses (1.310 × 10−3 mm2/s (Q1, Q3: 1.152, 1.560 × 10−3 mm2/s) than in benign masses (1.035 × 10−3 mm2/s; Q1, Q3: 0.900, 1.560 × 10−3 mm2/s) (P = 0.002) and in benign tumors compared by comparison with invasive masses (0.850 × 10−3 mm2/s; Q1, Q3: 0.750, 0.990 × 10−3 mm2/s) (P < 0.001). Solid tissue corresponded to irregular septa or papillary projection in 18.6% (47/253), to a mural nodule or a mixed mass in 46.2% (117/253), and to a purely solid mass in 35.2% (89/253) of adnexal masses. In mixed masses or masses with mural nodule subgroup, invasive masses had a significantly lower ADC (0.830 × 10−3 mm2/s (Q1, Q3: 0.738, 0.960) than borderline (1.385; Q1, Q3: 1.300, 1.930) (P = 0.0012) and benign masses (P = 0.04). An ADC cutoff of 1.08 × 10−3 mm2/s yielded 71.4% sensitivity and 100% specificity for identifying invasive lesions in the mixed or mural nodule subgroup with an AUC of 0.92 (95% confidence interval: 0.76–0.99).

Conclusion

ADC analysis of solid tissue of adnexal masses could help distinguish invasive masses within the O-RADS MRI 4 category, especially in mixed masses or those with mural nodule.

El texto completo de este artículo está disponible en PDF.

Keywords : Adnexal masses, MRI, O-RADS, Ovarian lesions, Stratification

Abbreviations : ADC, CI, DCE, DWI, EURAD, ICC, ICD-O, MRI, NPV, O-RADS, PPV, Q1, Q3, ROC, ROI, SD, SI, TIC, WHO


Esquema


© 2024  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 105 - N° 10

P. 386-394 - octobre 2024 Regresar al número
Artículo precedente Artículo precedente
  • Abdominal image quality and dose reduction with energy-integrating or photon-counting detectors dual-source CT: A phantom study
  • Joël Greffier, Djamel Dabli, Sebastian Faby, Maxime Pastor, Cédric Croisille, Fabien de Oliveira, Julien Erath, Jean Paul Beregi
| Artículo siguiente Artículo siguiente
  • Detection and characterization of pancreatic lesion with artificial intelligence: The SFR 2023 artificial intelligence data challenge
  • Theodore Aouad, Valerie Laurent, Paul Levant, Agnes Rode, Nina Brillat-Savarin, Pénélope Gaillot, Christine Hoeffel, Eric Frampas, Maxime Barat, Roberta Russo, Mathilde Wagner, Magaly Zappa, Olivier Ernst, Anais Delagnes, Quentin Fillias, Lama Dawi, Céline Savoye-Collet, Pauline Copin, Paul Calame, Edouard Reizine, Alain Luciani, Marie-France Bellin, Hugues Talbot, Nathalie Lassau

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

@@150455@@ Voir plus

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.